Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a
criptococică şi imunosupresie
Yüklə 4,39 Mb.
|
criptococică şi imunosupresie. Profilaxia secundară a candidozei orofaringiene la pacienţi cu imunosupresie. Tratamentul meningitei criptococice la pacienţii care nu pot lua sau nu tolerează amfotericina. Tratamentul candidozelor severe şi care pun în pericol viaţa la pacienţi care nu tolerează amfotericina. Tratamentul candidozei orofaringiene la pacienţi cu imunosupresie. Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului. ________________________________________________________________________________ DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J02AC01 FLUCONAZOLUM CAPS. 100 mg DIFLAZON 100 mg 100 mg KRKA D.D. FLUCONAZOLE TEVA 100 mg 100 mg TEVA PHARMACEUTICALS SRL FLUCORIC 100 mg 100 mg TERAPIA S.A. FLUCOVIM 100 100 mg VIM SPECTRUM SRL FUNGOLON 100 mg 100 mg BALKANPHARMA RAZGRAD AD
DIFLAZON 150 mg 150 mg KRKA D.D. DIFLUCAN 150 mg 150 mg PFIZER EUROPE MA EEIG FLUCONAZOL 150 mg 150 mg OZONE LABORATORIES LTD. FLUCONAZOL MEDICO UNO 150 mg 150 mg MEDICO UNO PHARMACEUTICAL SRL
FLUCONAZOL MEDOCHEMIE 150 mg 150 mg MEDOCHEMIE ROMANIA SRL FLUCONAZOL SANDOZ(R) 150 150 mg SANDOZ SRL FLUCONAZOL TERAPIA 150 mg 150 mg TERAPIA SA FLUCONAZOLE TEVA 150 mg 150 mg TEVA PHARMACEUTICALS SRL FLUCORIC 150 mg 150 mg TERAPIA S.A. FLUCOVIM 150 150 mg VIM SPECTRUM SRL MYCOMAX 150 150 mg ZENTIVA AS MYCOSYSTA(R) 150 mg 150 mg GEDEON RICHTER PLC. J02AC01 FLUCONAZOLUM CAPS. 200 mg DIFLAZON 200 mg 200 mg KRKA D.D. FLUCONAZOLE TEVA 200 mg 200 mg TEVA PHARMACEUTICALS SRL
DIFLAZON(R) 2 mg/ml KRKA D.D. DIFLUCAN(R) 2 mg/ml PFIZER EUROPE MA EEIG MYCOMAX(R) INF 2 mg/ml ZENTIVA AS J02AC01 FLUCONAZOLUM CAPS. 50 mg DIFLAZON 50 mg 50 mg KRKA D.D. DIFLUCAN 50 mg 50 mg PFIZER EUROPE MA EEIG FLUCONAZOL 50 mg 50 mg ARENA GROUP SA FLUCONAZOL MEDOCHEMIE 50 mg 50 mg MEDOCHEMIE ROMANIA SRL FLUCONAZOL SANDOZ(R) 50 50 mg SANDOZ SRL FLUCONAZOL TERAPIA 50 mg 50 mg TERAPIA S.A. FLUCONAZOLE TEVA 50 mg 50 mg TEVA PHARMACEUTICALS SRL FLUCORIC 50 mg 50 mg TERAPIA S.A. FLUCOVIM 50 50 mg VIM SPECTRUM SRL FUNGOLON 50 mg 50 mg BALKANPHARMA RAZGRAD AD
DIFLUCAN(R) 50 mg/5 ml 50 mg/5 ml PFIZER EUROPE MA EEIG ________________________________________________________________________________
| 889 |J02AC03| VORICONAZOLUM** | Protocol: J012B | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J02AC03 VORICONAZOLUM COMPR. FILM. 200 mg VFEND 200 mg 200 mg PFIZER LTD.
VFEND 200 mg 200 mg PFIZER LTD. J02AC03 VORICONAZOLUM PULB. PT. SUSP. ORALA 40 mg/ml VFEND 40 mg/ml 40 mg/ml PFIZER LTD. J02AC03 VORICONAZOLUM COMPR. FILM. 50 mg VFEND 50 mg 50 mg PFIZER LTD. ________________________________________________________________________________
| 890 |J02AC04| POSACONAZOLUM** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J02AC04 POSACONAZOLUM SUSP. ORALA 40 mg/ml NOXAFIL SP 40 mg/ml 40 mg/ml SP EUROPE ________________________________________________________________________________ ______________________________________________________________________________ | 891 |J02AX04| CASPOFUNGINUM** | Protocol: J010D | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J02AX04 CASPOFUNGINUM PULB. PT. CONC. PT. 50 mg SOL. PERF. CANCIDAS 50 mg 50 mg MERCK SHARP & DOHME LTD J02AX04 CASPOFUNGINUM PULB. PT. CONC. PT. 70 mg SOL. PERF. CANCIDAS 70 mg 70 mg MERCK SHARP & DOHME LTD ________________________________________________________________________________ ______________________________________________________________________________ | 893 |J05AB01| ACICLOVIRUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J05AB01 ACICLOVIRUM CAPS. 200 mg ACICLOVIR 200 mg 200 mg ARENA GROUP SA EUVIROX 200 mg 200 mg EUROPHARM SA J05AB01 ACICLOVIRUM COMPR. 200 mg ACICLOVIR 200 mg 200 mg TERAPIA SA CLOVIRAL 200 mg 200 mg ANTIBIOTICE SA ZOVIRAX 200 mg GLAXO WELLCOME FOUNDATION LTD.
ACICLOVIR 200 mg 200 mg OZONE LABORATORIES LTD. LOVIR 200 mg 200 mg RANBAXY UK LIMITED
INJ./PERF. VIROLEX 250 mg KRKA D.D. NOVO MESTO
ACICLOVIR 400 mg 400 mg ARENA GROUP S.A. J05AB01 ACICLOVIRUM COMPR. 400 mg ACICLOVIR 400 mg 400 mg EGIS PHARMACEUTICALS P.L.C.
ACIKLOVIR 400 mg A & G MED TRADING S.R.L. ________________________________________________________________________________
| 894 |J05AB11| VALACYCLOVIRUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J05AB11 VALACYCLOVIRUM COMPR. FILM. 500 mg VALTREX 500 mg 500 mg THE WELLCOME FOUNDATION LTD.
________________________________________________________________________________ ______________________________________________________________________________ | 895 |J05AB14| VALGANCICLOVIRUM** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J05AB14 VALGANCICLOVIRUM COMPR. FILM. 450 mg VALCYTE(R) 450 mg 450 mg ROCHE ROMANIA SRL ________________________________________________________________________________ ______________________________________________________________________________ | 897 |L01AA01| CYCLOPHOSPHAMIDUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. 1 g INJ./PERF. ENDOXAN(R) 1 g 1 g BAXTER ONCOLOGY GMBH L01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. 200 mg PERF./INJ. I.V. ENDOXAN 200 mg 200 mg ACTAVIS S.R.L.
INJ./PERF. ENDOXAN(R) 500 mg 500 mg BAXTER ONCOLOGY GMBH
ENDOXAN(R) 50 mg 50 mg BAXTER ONCOLOGY GMBH ________________________________________________________________________________
| 898 |L01AA03| MELPHALANUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L01AA03 MELPHALANUM COMPR. FILM. 2 mg ALKERAN 2 mg 2 mg THE WELLCOME FOUNDATION LTD.
________________________________________________________________________________ ______________________________________________________________________________ | 899 |L01AA06| IFOSFAMIDUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L01AA06 IFOSFAMIDUM PULB. PT. SOL. PERF. 1 g HOLOXAN 1 g 1 g BAXTER ONCOLOGY GMBH
HOLOXAN 2 g 2 g BAXTER ONCOLOGY GMBH L01AA06 IFOSFAMIDUM PULB. PT. SOL. PERF. 500 mg HOLOXAN 500 mg 500 mg BAXTER ONCOLOGY GMBH ________________________________________________________________________________
| 900 |L01AB01| BUSULFANUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L01AB01 BUSULFANUM COMPR. FILM. 2 mg MYLERAN 2 mg THE WELLCOME FOUNDATION LTD.
________________________________________________________________________________ ______________________________________________________________________________ | 901 |L01BA01| METHOTREXATUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L01BA01 METHOTREXATUM CONC. PT. SOL. 100 mg/ml INJ./PERF. METHOTREXAT "EBEWE" 1000 mg 100 mg/ml EBEWE PHARMA GMBH NFG. KG METHOTREXAT "EBEWE" 500 mg 100 mg/ml EBEWE PHARMA GMBH NFG. KG METHOTREXAT "EBEWE" 5000 mg 100 mg/ml EBEWE PHARMA GMBH NFG. KG L01BA01 METHOTREXATUM SOL. INJ./PERF. 10 mg/ml METHOTREXAT "EBEWE" 50 mg 10 mg/ml EBEWE PHARMA GMBH NFG. KG L01BA01 METHOTREXATUM PULB. PT. SOL. 50 mg INJ./PERF. ANTIFOLAN(R) 50 mg 50 mg SINDAN SRL
METHOTREXAT "EBEWE" 5 mg 5 mg/ml EBEWE PHARMA GMBH NFG. KG ________________________________________________________________________________
| 902 |L01BB05| FLUDARABINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L01BB05 FLUDARABINUM COMPR. FILM. 10 mg FLUDARA(R) ORAL 10 mg SCHERING AG
INJ./PERF. FLUDARA 50 mg SCHERING AG ________________________________________________________________________________ ______________________________________________________________________________ | 903 |L01CB01| ETOPOSIDUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L01CB01 ETOPOSIDUM CAPS. MOI 100 mg VEPESID 100 mg BRISTOL MYERS SQUIBB KFT
ETOPOSID "EBEWE" 100 mg/5 ml 100 mg/5 ml EBEWE PHARMA GMBH NFG. KG SINTOPOZID 100 mg/5 ml 100 mg/5 ml ACTAVIS S.R.L
ETOPOSIDE - TEVA 20 mg/ml TEVA PHARMACEUTICALS S.R.L.
VEPESID 50 mg BRISTOL MYERS SQUIBB KFT ________________________________________________________________________________
| 904 |L01DB06| IDARUBICINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L01DB06 IDARUBICINUM CAPS. 10 mg ZAVEDOS 10 mg PFIZER EUROPE MA EEIG
ZAVEDOS 5 mg 5 mg PFIZER EUROPE MA EEIG ________________________________________________________________________________
| 905 |L01DB07| MITOXANTRONUM** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L01DB07 MITOXANTRONUM CONC. PT. SOL. PERF. 2 mg/ml MITOXANTRONE TEVA 2 mg/ml 2 mg/ml TEVA PHARMACEUTICALS SRL
NOVANTRONE 20 mg/10 ml WYETH LEDERLE PHARMA GMBH L01DB07 MITOXANTRONUM CONC. PT. SOL. INJ. 2 mg/ml ONKOTRONE 2 mg/ml BAXTER ONCOLOGY GMBH ________________________________________________________________________________
| 906 |L01XA01| CISPLATINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L01XA01 CISPLATINUM LIOF. PT. SOL. PERF. 10 mg SINPLATIN 10 mg 10 mg ACTAVIS S.R.L.
CISPLATIN "EBEWE" 10 mg/20 ml 10 mg/20 ml EBEWE PHARMA GMBH NFG. KG CISPLATIN TEVA 10 mg/20 ml 10 mg/20 ml TEVA PHARMACEUTICALS S.R.L.
SINPLATIN 1 mg/1 ml 1 mg/1 ml ACTAVIS S.R.L.
CISPLATIN "EBEWE" 25 mg/50 ml 25 mg/50 ml EBEWE PHARMA GMBH NFG. KG L01XA01 CISPLATINUM LIOF. PT. SOL. PERF. 50 mg SINPLATIN 50 mg 50 mg ACTAVIS S.R.L. L01XA01 CISPLATINUM CONC. PT. SOL. PERF. 50 mg/100 ml CISPLATIN "EBEWE" 50 mg/100 ml EBEWE PHARMA GMBH NFG. KG 50 mg/100 ml ________________________________________________________________________________ ______________________________________________________________________________ | 907 |L01XA02| CARBOPLATINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L01XA02 CARBOPLATINUM CONC. PT. SOL. PERF. 10 mg/ml CARBOPLATIN "EBEWE" 10 mg/ml 10 mg/ml EBEWE PHARMA GES.M.B.H. NFG KG
CARBOPLATIN ACTAVIS 10 mg/ml 10 mg/ml ACTAVIS S.R.L. CARBOPLATIN TEVA 10 mg/ml 10 mg/ml TEVA PHARMACEUTICALS S.R.L. ________________________________________________________________________________ ______________________________________________________________________________ | 908 |L01XC04| ALEMTUZUMABUM** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L01XC04 ALEMTUZUMABUM CONC. PT. SOL. PERF. 10 mg/ml MABCAMPATH 10 mg/ml 10 mg/ml GENZYME EUROPE BV
MABCAMPATH 30 mg/ml 30 mg/ml GENZYME EUROPE BV ________________________________________________________________________________
| 909 |L01XC02| RITUXIMABUM** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L01XC02 RITUXIMABUM CONC. PT. SOL. PERF. 10 mg/ml MABTHERA 100 mg 10 mg/ml ROCHE REGISTRATION LTD. MABTHERA 500 mg 10 mg/ml ROCHE REGISTRATION LTD. ________________________________________________________________________________
| 910 |L03AA02| FILGRASTIMUM (G-CSF)** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L03AA02 FILGRASTIMUM SOL. INJ. 30 MU/0.5 ml (G-CSF) NEUPOGEN(R) 30 MU/0.5 ml AMGEN EUROPE B.V. L03AA02 FILGRASTIMUM SOL. INJ. 48 MU/0.5 ml (G-CSF)
NEUPOGEN(R) 48 MU/0.5 ml AMGEN EUROPE B.V. ________________________________________________________________________________ ______________________________________________________________________________ | 911 |L04AA01| CICLOSPORINUM | | |_______|_______|____________________________________________|_________________|
Monitorizarea atentă a pacienţilor este obligatorie. Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului. ________________________________________________________________________________ DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA01 CICLOSPORINUM CAPS. MOI 100 mg EQUORAL(R) 100 mg 100 mg IVAX - PHARMACEUTICALS S.R.O.
EQUORAL(R) 100 mg/ml IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL(R) 100 mg/ml NOVARTIS PHARMA GMBH L04AA01 CICLOSPORINUM CAPS. MOI 25 mg CICLORAL(R) HEXAL(R) 25 mg 25 mg HEXAL AG EQUORAL(R) 25 mg 25 mg IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL(R) 25 mg NOVARTIS PHARMA GMBH L04AA01 CICLOSPORINUM CAPS. MOI 50 mg CICLORAL(R) HEXAL 50 mg 50 mg HEXAL AG EQUORAL(R) 50 mg 50 mg IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL(R) 50 mg NOVARTIS PHARMA GMBH ________________________________________________________________________________ ______________________________________________________________________________ | 913 |L04AA05| TACROLIMUSUM** | | |_______|_______|____________________________________________|_________________|
Yüklə 4,39 Mb. Dostları ilə paylaş:
|